Farther Finance Advisors, LLC Seagen Inc. Transaction History

Farther Finance Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	N/A	-74 Closed	0 $0
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $13,788 - $15,563	72 Added 97.3%	146 $31 Million
Q2 2023 May 13, 2024	BUY	$187.64 - $206.25 $1,313 - $1,443	7 Added 10.45%	74 $14.2 Million
Q2 2023 Sep 12, 2023	BUY	$187.64 - $206.25 $1,313 - $1,443	7 Added 10.45%	74 $14.2 Million
Q1 2023 May 13, 2024	BUY	$127.59 - $203.08 $8,548 - $13,606	67 New	67 $13.6 Million
Q1 2023 Sep 12, 2023	BUY	$127.59 - $203.08 $637 - $1,015	5 Added 8.06%	67 $13.6 Million
Q4 2022 Sep 11, 2023	BUY	$117.37 - $139.17 $7,276 - $8,628	62 New	62 $7.97 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Farther Finance Advisors, LLC with notifications on news.